NCT04266977View on ClinicalTrials.gov

Restrictive Use of Dexamethasone in Glioblastoma

NARecruitingINTERVENTIONAL
Enrollment

50

Participants

Timeline

Start Date

May 8, 2020

Primary Completion Date

April 30, 2027

Study Completion Date

April 30, 2028

Conditions
GlioblastomaDexamethasoneSteroids
Interventions
DRUG

Dexamethasone

restrictive use of DEX, based on standardized clinical and radiological criteria.

Trial Locations (4)

3010

RECRUITING

Department of Neurosurgery, Bern

4031

NOT_YET_RECRUITING

Universitätsspital Basel, Basel

8091

NOT_YET_RECRUITING

Universitätsspital Zürich, Zurich

9007

NOT_YET_RECRUITING

Kantonsspital St. Gallen, Sankt Gallen

All Listed Sponsors
lead

Insel Gruppe AG, University Hospital Bern

OTHER